Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis

Journal of Immunology - United States
doi 10.4049/jimmunol.1202725
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Editorial: Cytotoxic CD4+ T Cells in Viral Infections

Frontiers in Immunology
AllergyImmunology
2017English

NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection

Journal of Immunology
AllergyImmunology
2016English

Cytotoxic CD4+ T Lymphocytes May Induce Epithelial Cell Apoptosis in Systemic Sclerosis

Journal of Clinical Investigation
Medicine
2020English

Dysregulated T Cells in Multiple Sclerosis

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2018English

The Transcription Factor Hobit Identifies Human Cytotoxic CD4+ T Cells

Frontiers in Immunology
AllergyImmunology
2017English

CD4+ Regulatory T Cell Responses Induced by T Cell Vaccination in Patients With Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Myeloid Cells as Target of Fingolimod Action in Multiple Sclerosis

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2015English

B Cells Are Capable of Independently Eliciting Rapid Reactivation of Encephalitogenic CD4 T Cells in a Murine Model of Multiple Sclerosis

PLoS ONE
Multidisciplinary
2018English

Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4+T Cells of Patients With Relapsing-Remitting Multiple Sclerosis

Journal of Immunology Research
MedicineAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy